Bioventus Inc.BVSNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank75
3Y CAGR-13.0%
5Y CAGR+9.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-13.0%/yr
vs +24.2%/yr prior
5Y CAGR
+9.1%/yr
Recent deceleration
Acceleration
-37.2pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $328.40M | -17.9% |
| 2024 | $400.20M | -2.4% |
| 2023 | $409.92M | -17.7% |
| 2022 | $498.31M | +71.5% |
| 2021 | $290.64M | +36.9% |
| 2020 | $212.28M | -2.6% |
| 2019 | $218.01M | +4.1% |
| 2018 | $209.50M | +21.1% |
| 2017 | $172.94M | +2.8% |
| 2016 | $168.22M | - |